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Introduction
Cancer cell metastasis is a multi-stage process that commences 
with local invasion of surrounding tissue. The ability of metastatic 
cells to invade requires reorganization of the actin-myosin cyto-
skeleton to facilitate the necessary morphological rearrange-
ments and ECM remodeling activities that permit movement from 
the primary site (Olson and Sahai, 2009). A sophisticated network 
of components, acting in response to Rho GTPase signal trans-
duction pathways, is responsible for the dynamic regulation of 
the actin-myosin cytoskeleton (Hall, 2009). As a consequence, 
there has been considerable interest in identifying critical ele-
ments in Rho GTPase signaling and actin-myosin regulation 
that are required for cancer cell invasion, with the long-term 
goal of developing pharmacological inhibitors that could pro-
vide  clinical  benefit  by  suppressing  local  dissemination  and 
metastatic spread (Walker and Olson, 2005; Olson, 2008).
The ability of tumor cells to move through tissues is the 
end product of two processes: ECM remodeling to generate a 
path of reduced mechanical resistance, and cell motility to fol-
low the path (Sahai, 2005). Although considerable recent effort 
has been focused on understanding how tumor cells invade 3D 
environments as individual cells, epithelial cancer cells com-
monly invade collectively in strands, sheets, and clusters (Friedl 
and Wolf, 2008). The cell collective may remain in contact with 
the tumor mass, or may detach and spread away from the pri-
mary site. In this form of invasion, leading cells generate paths 
of low physical resistance by focalizing protease activity and 
L
IM kinases 1 and 2 (LIMK1/2) are centrally positioned 
regulators  of  actin  cytoskeleton  dynamics.  Using 
siRNA-mediated knockdown or a novel small mole-
cule inhibitor, we show LIMK is required for path genera-
tion by leading tumor cells and nontumor stromal cells 
during collective tumor cell invasion. LIMK inhibition low-
ers cofilin phosphorylation, F-actin levels, serum response 
factor  transcriptional  activity  and  collagen  contraction, 
and reduces invasion in three-dimensional invasion as-
says. Although motility was unaffected, LIMK inhibition 
impairs matrix protein degradation and invadopodia   
formation  associated  with  significantly  faster  recovery 
times in FRAP assays indicative of reduced F-actin stabil-
ity. When LIMK is knocked down in MDA-MB-231 cells, 
they lose the ability to lead strands of collectively invading 
cells. Similarly, when LIMK activity is blocked in cancer-
associated fibroblasts, they are unable to lead the collective 
invasion of squamous carcinoma cells in an organotypic 
skin model. These results show that LIMK is required for 
matrix remodeling activities for path generation by leading 
cells in collective invasion.
LIM kinases are required for invasive path 
generation by tumor and tumor-associated  
stromal cells
Rebecca W. Scott,
1 Steven Hooper,
3 Diane Crighton,
2 Ang Li,
1 Ireen König,
1 June Munro,
1 Elisabeth Trivier,
4  
Grant Wickman,
1 Pierre Morin,
1 Daniel R. Croft,
1 John Dawson,
1 Laura Machesky,
1 Kurt I. Anderson,
1 Erik A. Sahai,
3 
and Michael F. Olson
1
1The Beatson Institute for Cancer Research and 
2Cancer Research Technology Ltd, Garscube Estate, Glasgow G61 1BD, Scotland, UK
3Cancer Research UK London Research Institute, London WC2A 3PX, England, UK
4Cancer Research Technology Ltd, Wolfson Institute for Biomedical Research, University College London, London WC1E 6BT, England, UK
©  2010  Scott  et  al.  This  article  is  distributed  under  the  terms  of  an  Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub-
lication date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
YJCB • VOLUME 191 • NUMBER 1 • 2010   170
proteins (Kleinman and Martin, 2005) was examined, cells in-
vaded as strand-like collectives as previously observed (Wolf et al., 
2007; Fig. 1 B and Video 1). After combined LIMK1/2 knock-
down, collective invasion was dramatically decreased (Fig. 1 B). 
By examining the extent of matrigel invasion by confocal micros-
copy at 15-µm optical sections, it was observed that the combined 
LIMK1/2 knockdown using two independent siRNA pairs resulted 
in statistically significant reduction in invasion relative to NT con-
trol siRNAs when comparing the ratio of cells that had migrated 
beyond a 45-µm cutoff (Fig. 1 C and Video 1). When LIMK1 or 
LIMK2 were knocked down individually there were small but non-
significant decreases in invasion, indicating that the combined out-
put of both kinases contributes to invasion (Fig. 1 C).
Because LIMK knockdown reduced cofilin phosphoryla-
tion, the effect of introducing additional unphosphorylated co-
filin by protein transduction on matrigel invasion was determined. 
An optimized protein transduction domain based on the HIV 
TAT protein (Ho et al., 2001) was fused to cofilin to promote 
cellular uptake. The F-actin severing activity (Hawkins et al., 
1993) of TAT-cofilin was validated in vitro using a pyrene fluor-
escence assay (Cano et al., 1991; Fig. 1 D). Control TAT-GST 
protein was not different from actin alone in the rate of pyrene 
fluorescence decay (Fig. 1 D). After introduction into MDA-
MB-231 cells of equivalent amounts of TAT-GST or unphos-
phorylated TAT-cofilin, comparable to endogenous cofilin levels, 
F-actin staining was reduced in the TAT-cofilin–treated cells 
compared with untreated or TAT-GST–treated cells (Fig. 1 E). 
In addition, a statistically significant effect of TAT-cofilin on 
inhibiting matrigel invasion compared with TAT-GST was ob-
served (Fig. 1 F). These results indicate that inhibiting LIMK 
activity  or  perturbing  the  ratio  of  phosphorylated  to  non-
phosphorylated cofilin had the same consequence of inhibiting 
3D collective invasion.
Stimulated by the potential of LIMK as a chemotherapeu-
tic target, small molecule inhibitors have been developed (Ross-
Macdonald et al., 2008). To determine whether LIMK inhibition 
would affect invasion, we tested the effects of N-{5-[2-(2,6-Di-
chloro-phenyl)-5-difluoromethyl-2H-pyrazol-3-yl]-thiazol-2-yl}-
isobutyramide (Fig. 2 A; compound 3 in Ross-Macdonald et al.,   
2008; hereafter referred to as LIMKi), a highly selective, non-
cytotoxic  and  potent  inhibitor  of  both  LIMK1  and  LIMK2. 
Treatment of MDA-MB-231 cells with LIMKi resulted in a dose-
dependent inhibition of cofilin phosphorylation, with a cell-
based IC50 of 1 µM (Fig. 2 B). Moreover, F-actin staining with 
phalloidin was similarly reduced by LIMK1/2 knockdown or by 
LIMKi treatment (Figs. 1 A and 2 C). When microscope settings 
were varied to acquire high resolution F-actin images of similar 
brightness, the only obvious effect was decreased intensity of 
cortical actin staining (Fig. 2 C). To more quantitatively examine 
F-actin intensity and organization, analysis of phalloidin-stained 
actin fibers using a Cellomics ArrayScan High Content Screening 
instrument followed by analysis using Morphology Explorer Bio-
Application software (which identifies intracellular fibers and 
measures morphology, alignment, and arrangement) indicated 
that there were no gross alterations in F-actin structures (Fig. 2 D). 
In agreement with observations made by microscopy (Fig. 2 C), 
LIMKi induced a dose-dependent reduction in F-actin signal 
generating force to remodel the ECM for the remainder of the 
collective to follow. As a result, distinct cells in strands may 
have different roles; for example path generation, which would 
require  ECM  remodeling  activities,  versus  path  following, 
which would only need cell motility. One advantageous aspect 
of this invasion mode is that stromal cells may be selected for, 
or  co-opted,  to  provide  the  path-generating  activity,  thereby 
contributing to tumor progression (Gaggioli, 2008).
The LIM kinases 1 and 2 (LIMK1 and LIMK2) are acti-
vated downstream of the Rho-ROCK, Rac-PAK, and Cdc42-
MRCK  pathways,  thereby  acting  as  network  nodes  in  the 
signaling pathways that regulate the actin cytoskeleton (Scott 
and Olson, 2007). There are numerous ways that activation of 
these Rho GTPases has been associated with human cancers, 
particularly  with  the  progression  to  invasive  and  metastatic 
stages (Sahai and Marshall, 2002; Benitah et al., 2004; Vega and 
Ridley, 2008). As a result, LIM kinases might present a vulner-
able locus in actin regulation, which when targeted could result 
in inhibition of invasion driven by any combination of upstream 
Rho GTPase signaling. When active, LIM kinases phosphory-
late and inactivate the F-actin severing functions of cofilin pro-
teins, resulting in F-actin stabilization (Van Troys et al., 2008).
We now show that inhibition of LIMK function by siRNA-
mediated knockdown or selective pharmacological inhibition 
with a first-in-class LIMK inhibitor blocks the collective inva-
sion of MDA-MB-231 breast carcinoma cells in 3D extra-
cellular matrices. In addition, LIMK activity was required for the 
collective invasion of squamous carcinoma cells (SCCs) in a 3D 
organotypic skin model. Although LIMK was not required for 
cell motility in two dimensions (2D), both ECM degrading and 
deforming activities were LIMK dependent in 3D. Consistent 
with this observation, LIMK activity was required in leading 
cells in MDA-MB-231 collective invasion as well as in leading 
fibroblasts in an organotypic SCC collective invasion model. 
However, LIMK activity was not required for path-following 
MDA-MB-231 or SCCs. These results reveal a requirement for 
LIMK activity in the path-generation function of leading cells 
in collective invasion.
Results
Collective invasion is blocked by LIMK 
inhibition or increased cofilin
To examine the contribution of LIMK to cell invasion, several 
siRNA duplexes for LIMK1 and LIMK2 were characterized. 
Independent LIMK1 and LIMK2 siRNAs efficiently knocked 
down their target, either alone or in combinations, as determined 
by Western blotting and RT-PCR (Fig. S1 A). Individual knock-
down of either LIMK1 or LIMK2 reduced phosphorylated co-
filin levels; combined LIMK1/2 knockdown further decreased 
phospho-cofilin compared with nontargeting (NT) siRNA trans-
fectants (Fig. S1 A) without affecting cell viability (Fig. S1 B). 
Consistent with a role in F-actin stabilization, combined LIMK1/2 
knockdown reduced phalloidin staining without notably affect-
ing cell morphology compared with control NT siRNA (Fig. 1 A).   
When the ability of MDA-MB-231 breast cancer cells to invade 
into a 3D matrix comprised of matrigel basement membrane 171 LIM kinases required for invasive path generation • Scott et al.
Figure 1.  LIMK activity is required for collective invasion. (A) Double LIMK1/2 knockdown (siLIMK1&2) in MDA-MB-231 breast cancer cells cultured on 
glass coverslips dramatically reduced cytoskeletal F-actin staining. Microscope settings were kept constant between conditions to assess staining intensity 
differences. Bar, 40 µm. (B) X-Z stack view of MDA-MB-231 invasion into 3D matrix revealed inhibition by LIMK1/2 knockdown. Bar, 25 µm. (C) Confocal 
images taken at 15-µM intervals through the 3D matrix revealed significant inhibition of invasion for two independent siRNA duplex pairs against LIMK1/2 
relative to NT control siRNA. Individual targeting of LIMK1 (siL1) or LIMK2 (siL2) did not significantly reduce invasion. Bar, 100 µm (average ± SEM, n = 3). 
(D) Recombinant TAT-Cofilin protein severed F-actin in vitro. (E) Recombinant TAT-Cofilin reduced phalloidin-stained F-actin structures in MDA-MB-231 breast 
cancer cells cultured on glass coverslips. Confocal microscope settings were kept constant between conditions. Bar, 40 µm. (F) Addition of cell-permeable 
TAT-Cofilin significantly inhibited 3D matrix invasion relative to equal mass of TAT-GST control. Bar, 100 µm (average ± SEM, n = 3).JCB • VOLUME 191 • NUMBER 1 • 2010   172
Figure 2.  Selective LIMK inhibitor affects actin dynamics and blocks collective invasion. (A) Structure of LIMK inhibitor (LIMKi). (B) LIMKi reduced cofilin 
phosphorylation in MDA-MB-231 breast cancer cells cultured on plastic in a dose-dependent manner as detected by Licor Odyssey two-color infrared 
scanning. (C) Cytoskeletal F-actin staining was reduced in MDA-MB-231 breast cancer cells cultured on glass coverslips by LIMK inhibitor. Confocal 
microscope settings were kept constant between the top three rows of images. Settings were varied in the actin high resolution (Res.) row to allow for 
comparable image acquisition of F-actin structures. Bar, 20 µm (top three rows) or 40 µm. (D) Actin fiber analysis by ArrayScan HCS Morphology 
Explorer BioApplication of MDA-MB-231 breast cancer cells grown on glass-bottomed dishes and treated with indicated LIMKi concentrations revealed 
no detectable changes in F-actin morphology but decreased overall staining intensity (averages ± SEM, n = 3). (E) Activation of the serum response   173 LIM kinases required for invasive path generation • Scott et al.
that promote uniaxial polarity resulting in efficient directional 
protrusion (Doyle et al., 2009). Tracks of individual cell move-
ment did not differ after LIMK1/2 knockdown from NT siRNA-
transfected cells (Fig. 3 B, Video 2). Analysis of individual cell 
motility from multiple experiments revealed that the vectorial 
distances (from start to end points) covered were not different; 
nor was the accumulated distance (total track length) different 
for NT or LIMK1/2 siRNA-transfected cells (Fig. 3 C). Persistence 
of movement, which is a directional ratio of vectorial over accumu-
lated distances, also did not differ between treatments (Fig. 3 C). 
These results indicate that the directionality and velocity of cell 
motility  driven  by  cell-intrinsic  factors  on  fibroblast-derived 
oriented matrices were as unaffected by LIMK inhibition as was 
wound-healing–induced motility on uncoated substrata.
LIMK inhibition impairs matrix degradation
Because LIMK inhibition significantly reduced invasion into a 
3D matrix without affecting cell motility, one possibility was 
that the processes required for path generation were affected. 
Collective invasion requires proteolytic remodeling of ECM for 
leading cells to initiate path generation. To quantitate the re-
quirement for LIMK in focalized ECM proteolysis, MDA-
MB-231 cells were plated on top of a thin layer of fluorescent 
gelatin to assess invadopodia formation (Buccione et al., 2009). 
Consistent with previous reports (Lizárraga et al., 2009), MDA-
MB-231 cells had large numbers of actin-rich projections into 
the gelatin matrix, which were evident by discrete dark foci re-
sulting from matrix metalloprotease (MMP)–mediated degrada-
tion of the protein matrix (Stylli et al., 2008; Fig. 4 A, arrows). 
Colocalization  of  matrix  degradation  sites  with  MMP9  and   
the actin polymerization regulator N-Wasp (Fig. 4 B) or with 
phalloidin-stained F-actin (Fig. S4 A) further validates these 
structures as invadopodia. In addition, sites of matrix degradation 
also showed colocalization of cortactin with F-actin (Fig. S4 B) 
or with N-Wasp (Fig. S4 C). LIMKi treatment at 3 or 10 µM or 
LIMK1/2 knockdown significantly reduced the area of gelatin 
degradation per cell (Fig. 4 C). Generation of active invado-
podia requires the accumulation of cortactin to invadopodia 
precursors followed by F-actin stabilization during maturation 
(Artym et al., 2006; Oser et al., 2009). Treatment with 10 µM 
LIMKi, which significantly reduced gelatin degradation in inva-
dopodia structures (Fig. 4 C), did not affect cortactin accumula-
tion into distinct punctae (Fig. 4 D). One alternative possibility, 
therefore, was that LIMK inhibition did not allow for sufficient 
F-actin stabilization for invadopodia maturation into fully func-
tional structures. Cells were transfected with GFP-actin and 
FRAP was used to determine the half times (t1/2) of recovery in 
punctate F-actin structures typical of invadopodia. Treatment 
with LIMKi significantly reduced the t1/2 of recovery (Fig. 4 E), 
indicating that LIMK activity was required for F-actin stabiliza-
tion in these structures. These results indicate that LIMK inhibition 
intensity (Fig. 2 D). Additional morphometric analysis revealed 
no significant changes in size parameters or cell shape (Fig. S2, 
A and B). Consistent with published results (Ross-Macdonald 
et al., 2008), LIMKi had no effect on microtubule number or 
organization (Fig. S3). Cofilin phosphorylation by LIMK was 
previously  reported  to  activate  serum  response  factor  (SRF) 
transcriptional activity (Geneste et al., 2002). Measurement of 
SRF activity using the 3D.Aluc reporter, which contains a lucif-
erase reporter controlled by three SRF binding sites (Copeland 
and Treisman, 2002), showed that serum-stimulated SRF ac-
tivity was reduced by LIMK1/2 knockdown or by LIMKi to a 
similar degree (Fig. 2 E). A kinetic adhesion/spreading assay, in 
which the electrical impedance of a set number of cells plated 
on a grid of electrodes was measured (cell index), revealed 
that after comparable patterns of initial adhesion there was an 
increase in cell spreading on fibronectin over 24 h proportional 
to LIMKi dose (Fig. 2 F). These results indicate that LIMKi 
potently inhibits LIMK activity and biological outputs compa-
rable to LIMK1/2 knockdown. When tested in the 3D matrigel 
invasion assay, there was significant dose-dependent inhibition 
of matrigel invasion with a greater than 50% effect at 3 µM 
LIMKi (Fig. 2 G). These results confirm the dependence of 
MDA-MB-231 cell invasion on LIMK activity and demonstrate 
that pharmacological inhibition of LIMK activity reduces tumor 
cell invasion.
LIMK inhibition does not affect 2D motility
A circular wound-healing assay was used to determine the   
effects of LIMK inhibition on the migration of cells on a 2D 
surface. After the removal of a central stopper that blocks   
adherence to create a uniform cell-free zone, effects on cell mi-
gration were monitored (Fig. 3 A). Knockdown of LIMK1/2 by 
two independent siRNA pairs had no effect on cell migration after   
24 h (Fig. 3 A). Consistent with these results, treatment with 
LIMKi concentrations from 0.1 to 3 µM also had no effect on 
wound healing (Fig. 3 A).
One possible explanation for the lack of effect of LIMK 
inhibition was that 2D migration across a rigid substratum is 
principally propelled by actin polymerization and forward pro-
trusion (Olson and Sahai, 2009), and because cofilin activation 
could result in F-actin severing and increased density of barbed 
ends available to provide sites for monomer addition and fila-
ment extension, LIMK inhibition and consequent cofilin activa-
tion would not necessarily impair protrusion-driven motility. 
We next examined the effects of blocking LIMK activity on cell 
motility on an oriented 3D fibrillar ECM generated by primary 
cultured human dermal fibroblasts (Cukierman et al., 2001). 
Cell motility in this model does not require the generation of 
low-resistance paths by ECM remodeling, but movement is de-
pendent upon engagement of 51 integrins (Cukierman et al., 
2001) and is guided by a meshwork of long fibronectin fibrils 
factor transcriptional reporter by serum stimulation of MDA-MB-231 breast cancer cells cultured on plastic was comparably blocked by double LIMK1/2 
knockdown or by LIMK inhibitor (averages ± SEM; left graph, n = 3; right graph, n = 5). (F) The cell index, measured by electrical impedance using the 
xCELLigence system, was measured over time for cells plated on fibronectin-coated wells in the presence of DMSO or increasing concentrations of LIMKi 
as indicated (averages of n = 3). (G) Confocal sectioning of 3D matrix invasion by MDA-MB-231 cells revealed a significant dose-dependent inhibition 
by LIMKi. Bar, 200 µm average ± SEM, n = 3).
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knockdown or inhibition (Fig. 4 C), LIMK1/2 knockdown re-
sulted in loss of focalized MMP9 immunostaining (Fig. 5 A). 
Because MMP activity in invadopodia is required for direct pro-
teolytic actions on the ECM (Artym et al., 2006; Poincloux et al., 
2009), but also for the secretion and/or activation of soluble 
proteases such as MMP9 (Itoh and Seiki, 2004), we examined 
significantly affected ECM degradation in 2D contexts, likely 
by inhibiting the formation of stable actin structures necessary 
for invadopodia maturation that focalizes MMP activity for 
matrix degradation.
Consistent  with  MMP9  localization  to  invadopodia   
(Fig. 4 B) and the reduction in invadopodia formation by LIMK 
Figure 3.  LIMK activity is not required for 2D cell motility. (A) A modified scratch-wound assay in which stoppers were used to produce regular and re-
producible cell-free zones was used to monitor cell motility. Diameter of circle = 2 mm. LIMK1/2 double knockdown with two independent siRNA duplex 
pairs did not affect MDA-MB-231 wound closing on uncoated glass-bottomed multi-well plates relative to NT control siRNA. Treatment with increasing LIMKi 
doses also did not affect wound closing (average ± SEM, n = 4). (B) The random migration of MDA-MB-231 cells transfected with NT or LIMK1/2 siRNA on 
an oriented 3D fibrillar ECM generated by primary cultured human dermal fibroblasts was determined by time-lapse microscopy. Tracks of individual cells 
revealed no obvious differences in path length, direction, or velocity. Bar, 100 µm. (C) Analysis of vectorial distance, accumulated distance, and persistence 
with ImageJ revealed no differences in 2D cell motility on fibroblast-derived matrix between NT or LIMK1/2 siRNA transfectants (average ± SEM, n = 4).175 LIM kinases required for invasive path generation • Scott et al.
Figure 4.  LIMK inhibition blocks invadopodia formation by decreasing F-actin stability. (A) X-Y, X-Z, and Z-Y views of a fixed MDA-MB-231 cell stained for 
F-actin (red) plated on FITC-labeled gelatin (green). Invadopodia are actin-rich projections within dark regions, indicative of gelatin degradation. Bar, 
10 µM. (B) X-Y and X-Z views of a fixed MDA-MB-231 cell stained for N-Wasp (green) and MMP9 (red) plated on Oregon Green 488–labeled gelatin 
matrix (gray). Invadopodia are regions of gelatin degradation that colocalize with N-Wasp and MMP9. Bar, 10 µM. (C) LIMKi or LIMK1/2 knockdown 
with two independent duplex pairs significantly reduced invadopodia formation and consequent area of gelatin degradation relative to vehicle control and 
NT controls, respectively. Microscope settings were varied to acquire images of similar intensity for comparison purposes. Insets show higher magnification. 
Bar, 10 µM (averages ± SEM, n = 3). (D) Cortactin localization in cells plated on gelatin was unaffected by LIMKi treatment (box equals upper and lower 
quartiles with line indicating median, whiskers are 5 and 95% confidence intervals, n = 90 per treatment). Bar, 10 µM. (E) FRAP analysis of cells plated 
on gelatin and expressing GFP-actin revealed that LIMKi significantly decreased the t1/2 of recovery relative to vehicle DMSO-treated cells. Bar, 10 µM 
(average ± SD; untreated n = 16; LIMKi n = 26).JCB • VOLUME 191 • NUMBER 1 • 2010   176
cells were transfected with LIMK1/2 siRNA there were fewer 
RFP-positive cells invading into matrigel, and the RFP-expressing 
cells observed were largely restricted to following GFP-positive 
cells (Fig. 6 C), with the occurrence of RFP expressers as lead-
ing cells significantly dropping to less than 20% (Fig. 6 D). 
When the identities of the “second cell” following immediately 
after the leading cell were assessed, there was no difference in 
the incidence of RFP-expressing cells in this position between 
NT or LIMK1/2 siRNA transfectants (Fig. 6 E). Consistent with 
the critical role of MMP9 in MDA-MB-231 invasion (Fig. 5 F), 
MMP9 knockdown in RFP expressers significantly impaired 
their ability to be leading cells (Fig. 6 F). These results indicate 
that LIMK and MMP9 activity are required for path generation 
by leading cells in collective invasion. However, similar to the 
lack of effect on 2D motility (Fig. 3), LIMK activity was dis-
pensable for path following (Fig. 6 E).
Fibroblast-led collective invasion requires 
LIMK for path generation
The full repertoire of activities necessary for collective invasion 
is intrinsic to MDA-MB-231 cells (Wolf et al., 2007). It is also 
possible for noninvasive cells to become invasive by following 
tracks laid down by other path-generating cells; in fact path gen-
eration may occur temporally in advance of invasion (Gaggioli   
et al., 2007). We used an organotypic culture model in which the 
invasiveness of SCCs, which retain epithelial markers and do 
not invade on their own, is dependent upon stromal fibroblasts 
to remodel the ECM and generate paths (Gaggioli et al., 2007; 
Gaggioli, 2008). SCCs were grown, supported by a metal bridge 
to allow the upper surface to be exposed to air and the lower 
surface to be in contact with media, on a dense matrix composed 
primarily of fibrillar collagen I. Although unable to invade alone, 
SCCs were able to efficiently invade when cancer-associated fibro-
blasts (CAF) were present in the matrix (Fig. 7 A). Although 
DMSO vehicle had no effect on invasion, there was a dose- 
dependent decrease in SCC invasion in response to increasing 
LIMKi concentrations attaining comparable inhibition to ROCK 
inhibitor Y-27632 at 10 µM (Fig. 7 A). To determine the LIMKi 
target cells, CAF cells were embedded in matrix either in the 
absence or presence of increasing doses of LIMKi, allowed to 
generate paths for five days, then killed with puromycin. After 
extensive washes, SCCs were seeded on top of the matrix and 
allowed to invade. Alternatively, CAF cells were allowed to 
generate tracks for five days, killed with puromycin, and then 
SCCs were seeded in the absence or presence of increasing 
LIMKi concentrations and allowed to invade. When CAFs were 
incubated with LIMKi, there was a dose-dependent inhibition 
in SCC invasion (Fig. 7 B). In contrast, treatment of SCCs with 
LIMKi at the same doses that had inhibited invasion in Fig. 7 A 
had no effect on SCC invasion (Fig. 7 B), indicating again that 
path following was not affected by LIMK inhibition. To confirm 
that LIMK was the critical target, knockdown of LIMK1/2 in 
CAFs with two independent siRNA pairs significantly inhibited 
SCC invasion, whereas neither mock transfection or NT siRNA 
affected invasion (Fig. 7 C). In contrast, knockdown of LIMK1/2 
in SCCs did not significantly affect invasion, although Cdc42 
knockdown significantly reduced invasion (Fig. 7 D), again 
matrix degradation in a 3D context. Cells were plated at low 
density in a 3D matrigel environment mixed with dye-quenched 
(DQ) collagen, which is so heavily conjugated with fluorescein 
that the fluorescent signal is quenched until proteolysis sepa-
rates collagen fragments, thereby lowering the local fluorescein 
concentration and permitting fluorescence. As shown in Fig. 5 B, 
RFP-labeled MDA-MB-231 cells transfected with NT siRNA 
were associated with strong fluorescence both adjacent to the 
cells and more distant. In marked contrast, cells transfected 
with both LIMK1/2 siRNA had much lower levels of fluores-
cence, both distal and proximal to the cells, indicating reduced 
proteolytic activity (Fig. 5 B). Conditioned media from NT or 
LIMK1/2 siRNA-transfected cells was collected and concen-
trated before electrophoresis in gelatin-containing polyacryl-
amide  zymography  gels;  in  parallel  whole-cell  lysates  were 
prepared for Western blotting. LIMK1/2 knockdown reduced 
both  proteins  and  cofilin  phosphorylation  without  affecting 
MT1-MMP or MMP9 expression (Fig. 5, C and D). However, 
LIMK1/2 knockdown reduced the 86-KD gelatin-degradation 
activity (the size of activated MMP9; Lindenmeyer et al., 1997) 
almost to the background levels observed in concentrated   
serum-containing media (Fig. 5 C). To determine whether the 
effect on secreted MMP9 activity was specific to LIMK inhibition 
or due to reduced invadopodia formation, cells in which Fascin 
had been knocked down with two independent shRNA hairpins 
were examined for invadopodia formation and secreted MMP9 
activity. Consistent with previous results (Li et al., 2010), Fas-
cin  knockdown  significantly  reduced  invadopodia  formation 
(Fig. 5 E). In addition, although MMP9 levels in whole-cell lysates 
were not affected, Fascin knockdown did reduce the level of se-
creted MMP9 activity in concentrated media (Fig. 5 E). Consistent 
with previous results (Kunigal et al., 2007), MMP9 knockdown 
significantly reduced MDA-MB-231 invasion (Fig. 5 F). These   
results indicate that 3D ECM degradation, secretion/activation 
of MMP9, and 3D invasion are dependent on the formation of 
the LIMK-dependent stable actin structures that are also re-
quired  for  invadopodia  formation.  The  inability  to  remodel 
ECM by proteolysis, without affecting 2D motility, again sug-
gests that LIMK inhibition likely affects path generation in col-
lective invasion rather than path following.
LIMK is required in leading path-generating 
cells for collective invasion
The invasion of MDA-MB-231 cells into 3D matrigel was via 
collective strands (Fig. 1 B and Video 1; Wolf et al., 2007). 
Confirming that there were multiple cells within strands, fixa-
tion and staining with FITC-phalloidin and propidium iodide (PI) 
revealed numerous PI-stained nuclei within each strand (Fig. 6 A). 
Because MDA-MB-231 cells are capable of providing the path-
generating activity required in leading cells during collective 
invasion, we labeled pools of cells with either membrane- 
tethered GFP or RFP. While GFP-expressing cells were left un-
treated, RFP-expressing cells were transfected either with NT 
or LIMK1/2 siRNA. Consistent with the results in Fig. 1, B and D, 
NT siRNA did not affect matrigel invasion (Fig. 6 B) and the 
occurrence  of  RFP  expressers  as  leading  cells  in  collective 
strands was 50% (Fig. 6 D). However, when RFP-expressing 177 LIM kinases required for invasive path generation • Scott et al.
Figure 5.  Inhibition of invadopodia formation reduces levels of active secreted MMP9 and matrix degradation. (A) Focalized MMP9 immunostaining in 
MDA-MB-231 cells plated on gelatin was reduced after LIMK1/2 knockdown. Bar, 10 µM. (B) RFP-labeled MDA-MB-231 cells plated in matrix-containing 
dye-quenched (DQ) collagen reveal considerable proteolytic activity that was reduced by LIMK1/2 knockdown. Bar, 20 µm. (C) LIMK1/2 knockdown in 
MDA-MB-231 cells plated on plastic, which decreased cofilin phosphorylation, did not alter MT1-MMP or MMP9 protein levels in cell lysates but did reduce 
levels of MMP9 activity in conditioned media. (D) Although LIMK1/2 knockdown in MDA-MB-231 cells plated on plastic reduced soluble MMP9-like activ-
ity, there was no effect on MMP9 expression as determined by RT-PCR. (E) Inhibition of invadopodia formation on gelatin by stable Fascin knockdown was 
associated with reduced levels of MMP9 activity in conditioned media but not in lysates from cells plated on plastic. Microscopy settings were varied to 
acquire images of similar intensities. Bar, 10 µm (averages ± SD, n = 180). (F) Knockdown of MMP9 significantly inhibited invasion into 3D matrix relative 
to control NT siRNA. Western blot shows MMP9 knockdown compared with AKT loading controls. Bar, 200 µm (averages ± SEM, n = 3).JCB • VOLUME 191 • NUMBER 1 • 2010   178
LIMK activity is required for ECM 
deformation
In  addition  to  ECM  proteolysis,  force-mediated  remodeling 
contributes to the path generation that permits collective inva-
sion (Gaggioli et al., 2007). Key drivers of actin-myosin con-
tractile force and matrix deformation enabling tumor cell invasion 
are the ROCK kinases (Wyckoff et al., 2006), which phosphory-
late a number of substrates that lead to increased myosin light 
chain phosphorylation (pMLC) (Riento and Ridley, 2003). 
Treatment of MDA-MB-231 cells plated on a pliable collagen 
matrix with LIMKi did not affect pMLC levels, although ROCK 
inhibitor Y27632 significantly lowered pMLC (Fig. 8 A), indi-
cating that LIMK does not directly trigger force generation by 
this mechanism. When CAFs were mixed with ECM and plated 
in the wells of 96-well tissue culture plates, there was a significant 
consistent with LIMK activity not being required for path follow-
ing (Gaggioli et al., 2007). Unlike MDA-MB-231 cells (Fig. 5 F), 
CAFs did not express detectable levels of MMP9; instead, 
MT1-MMP was highly expressed (Fig. S5). Given that LIMK 
was required for collective invasion (Fig. 1) and ECM degradation 
(Figs. 4 C and 5 B), we examined whether direct reduction of MMP 
activity in path-generating CAFs would reduce SCC invasion as 
was the case for leading MDA-MB-231 cells (Fig. 6 F). Knock-
down of MT1-MMP expression with three individual siRNA   
duplexes in CAFs significantly reduced SCC invasion (Fig. 7 E). 
These results indicate that the path-generating activity of ECM deg-
radation provided by CAFs was targeted by LIMK inhibition, and 
that the ability of SCCs to move through preformed paths through 
ECM was unaffected, reinforcing the conclusion that LIMK activity 
is critical for invasive path generation but not path following.
Figure 6.  LIMK activity is required for path generation in collective invasion. (A) To confirm that MDA-MB-231 strands invading 3D matrix were com-
prised of cell collectives, fixation and staining of F-actin (green) and DNA (red) revealed multiple cells within strands. Bar, 20 µM. (B) Separate pools of 
MDA-MB-231 cells were labeled either with RFP or GFP, then RFP-expressing cells were transfected either with NT or LIMK1/2 siRNA targeting duplexes 
as indicated. Untreated GFP-expressing cells were combined with siRNA-transfected RFP-expressing cells and the mixture assayed for 3D matrix invasion. 
Strands were equally led by GFP-expressing or NT-transfected RFP-expressing cells. Bar, 20 µM. (C) LIMK1/2 knockdown blocked the occurrence of lead-
ing RFP-expressing cells, although RFP-labeled cells were still observed after GFP-expressing cells. Bar, 20 µM. (D) 3D reconstructions of confocal image 
stacks were assembled with Volocity software, and used to assess the incidence of GFP or RFP cells leading collective invasion strands. Although there was 
no difference when cells were transfected with NT siRNA, LIMK1/2 knockdown significantly reduced the ability of RFP-expressing cells to lead collective 
invasion (average ± SEM, n = 4). (E) When the identity of the cell immediately after the leading cell was determined, there were no differences in the NT 
or LIMK1/2 siRNA-transfected RFP-expressing cells to follow in the second position (average ± SEM, n = 5). (F) Although there was no difference when 
cells were transfected with NT siRNA, MMP9 knockdown significantly reduced the ability of RFP-expressing cells to lead collective invasion (average ± 
SEM, n = 3).179 LIM kinases required for invasive path generation • Scott et al.
Figure 7.  Collective invasion of squamous cell carcinoma requires LIMK activity in leading stromal fibroblasts. (A) The ability of squamous carcinoma 
cells (SCC) that retain epithelial markers to invade 3D matrix is dependent on stromal fibroblasts. LIMKi significantly inhibited SCC invasion in a dose-
dependent manner. Photomicrographs indicate effects of LIMKi or Y27632 on SCC invasion. Bar, 100 µm. (B) Paths were allowed to be generated by 
fibroblasts, which were then removed by puromycin extraction before the addition of the SCC layer. Increasing LIMKi doses were either included only after 
path generation by fibroblasts was allowed to occur (SCCs targeted) or during fibroblast-mediated path generation (Fibroblasts targeted), as indicated. 
Significant inhibition of SCC invasion occurred specifically when fibroblasts were targeted, indicating that path generation but not path following required 
LIMK activity (averages ± SEM, n = 5). (C) To determine whether LIMK activity was required in fibroblasts for SCC invasion, two independent siRNA duplex 
pairs targeting LIMK1/2 were used to knock down expression. Relative to mock or NT siRNA-transfected cells, LIMK1/2 knockdown significantly reduced 
SCC invasion (averages ± SEM, n = 4). (D) To corroborate the dispensability of LIMK in SCC for invasion, two independent siRNA duplex pairs targeting 
LIMK1/2 were used to knockdown expression. Relative to mock or NT siRNA-transfected cells, LIMK1/2 knockdown did not significantly affect invasion, 
although Cdc42 knockdown did reduce invasion (averages ± SEM, n = 4). (E) Knockdown of MT1-MMP with three independent siRNA duplexes signifi-
cantly reduced SCC invasion (averages ± SEM, n = 15).JCB • VOLUME 191 • NUMBER 1 • 2010   180
(Fig. 9 B). The path-generating function may be provided by 
leading tumor cells or by stromal cells; in either case LIMK in-
hibition blocked their ability to make paths, but not to follow 
preformed paths or the paths made by noninhibited cells in col-
lective invasion (Fig. 9 B). Global LIMK inhibition blocked in-
vasion because the ECM remodeling processes necessary for 
path generation were no longer active (Fig. 9 B).
The ability of tumor cells to invade and spread is critically 
dependent upon dynamic and regulated rearrangements to the 
actin-myosin cytoskeleton (Olson and Sahai, 2009). F-actin fil-
aments are in a constant state of flux with new monomers being 
added at the plus end, depolymerization at the minus end, and 
F-actin severing occurring within the filament. Due to the com-
plexity of these dynamic processes and their importance to cellu-
lar homeostasis, a vast number of proteins contribute in numerous 
ways to their regulation. Although it might seem that the effect 
of altering the input from a single protein would be unlikely to 
produce a significant change in output, data from clinical and 
basic studies indicate that LIM kinases are important factors in 
cancer cell invasion and metastasis (Davila et al., 2003; Yoshioka   
et al., 2003; Wang et al., 2004; Okamoto et al., 2005; Bagheri-
Yarmand et al., 2006). In support of this conclusion, results 
from in vivo studies indicated that interfering with LIMK func-
tion inhibited metastasis (Yoshioka et al., 2003; Vlecken and 
Bagowski, 2009). These reports are consistent with the hypothesis 
that LIM kinases are important regulators of actin cytoskeleton 
dynamics and that LIMK inhibition would effectively reduce 
cancer cell invasion and metastasis. The results from this study also 
support the possibility that pharmacological LIMK inhibition 
will be efficacious in blocking the spread of metastatic cancers.
Although numerous lines of basic and clinical research 
support LIMK as a positive factor in cell motility and/or inva-
sion (Yoshioka et al., 2003; Nishita et al., 2005; Kobayashi et al., 
2006; Ding et al., 2008; Horita et al., 2008; Mishima et al., 
2010), the field has not been without controversy as it has also 
been reported that LIMK expression may have an inhibitory effect 
on cell motility and invasion. Indeed, we found that expression 
of full-length LIMK1 inhibited MDA-MB-231 invasion (un-
published data) and decreased the motility of Ras-transformed 
Swiss 3T3 fibroblasts (Sahai et al., 2001). In addition, over-
expression of LIMK1 in MTLn3 rat mammary carcinoma cells in-
hibited lamellipod extensions (Zebda et al., 2000), EGF-stimulated 
motility, and in vivo invasion (Wang et al., 2006). These seem-
ingly contradictory observations may be explained if the rela-
tionship between LIMK and cofilin is not considered as a simple 
linear pathway in which more LIMK activity equals more co-
filin phosphorylation equals more invasion. Instead, the dynamic 
cycling of cofilin between inactive and active states (the “cofilin 
activity cycle”) influenced significantly by phosphorylation/de-
phosphorylation must be regarded as a key determinant of invasive 
and metastatic potential (Oser and Condeelis, 2009; van Rheenen 
et  al.,  2009).  Depending  on  the  initial  starting  point,  small 
changes in LIMK activity and consequent cofilin phosphoryla-
tion could induce increased or decreased cell invasiveness depend-
ing on whether the cofilin activity cycle was moving toward or 
away from an optimal state. If the hypothesis that cancer cells ac-
quire the ability to invade and metastasize as one of the “hallmarks 
dose-dependent decrease in ECM contraction in response to in-
creasing LIMKi concentrations (Fig. 8 B). In addition, there was 
a significant decrease in ECM contraction when LIMK1/2 were 
knocked down relative to NT controls (Fig. 8 C). Because LIMK 
inhibition blocked both ECM degradation (Figs. 4 C and 5 B) and 
ECM contraction (Fig. 8, B and C), we directly examined whether 
there was a requirement for MMP activity in ECM contraction. 
Consistent  with  MT1-MMP  promoting  collagen  contraction 
(Deryugina et al., 1998), knockdown of MT1-MMP with three 
independent siRNA duplexes reduced contraction of collagen 
by CAFs (Fig. 8 D). Similar to the lack of effect of LIMKi on 
pMLC,  MT1-MMP  knockdown  did  not  affect  pMLC  levels 
(Fig. 8 E). These results indicate that both LIMK and MT1-
MMP are required for matrix deformation without affecting 
MLC phosphorylation, suggesting MMPs facilitate contraction 
by breaking down the cross-linking that makes the ECM rigid to 
allow for subsequent contraction, which additionally contributes 
to the ECM remodeling required for invasive path generation.
Discussion
The ability of tumor cells to spread from a primary mass is de-
pendent  on  ECM  remodeling  to  generate  paths  that  permit 
movement, and on motility to move through the paths. Many 
cancer cells, when plated on substrates composed of matrix pro-
teins, form ventral actin-rich structures called invadopodia that 
are associated with ECM proteolytic activity (Yamaguchi et al., 
2006; Linder, 2007; Buccione et al., 2009). The ability of can-
cer cells to make invadopodia often correlates with their ability 
to enter the vasculature (Yamaguchi et al., 2006), and as such 
likely are a representation of the ECM degrading activities that 
facilitate invasive path generation. The formation of invadopodia 
requires the activity of the actin-nucleating Arp2/3 complex, 
which is regulated by cortactin (Yamaguchi et al., 2005; Oser 
and Condeelis, 2009; Oser et al., 2009). The birth, growth, and 
maturation of invadopodia takes place over a number of stages 
(Artym et al., 2006; Oser et al., 2009; Schoumacher et al., 2010; 
Fig. 9 A): (1) Accumulation of cortactin and recruitment of actin 
polymerization machinery including Arp2/3 and N-Wasp at sites 
of membrane adherence to ECM; (2) F-actin extension and sta-
bilization; and (3) recruitment of microtubules and intermediate 
filaments for invadopodia elongation and delivery of MMPs.   
Although cortactin foci were still formed (Fig. 4 D), the stabil-
ity of F-actin structures was significantly reduced when LIMK 
was inhibited (Fig. 4 E). In addition, the accumulation of discrete 
subcellular structures containing MMP9 and ECM proteolytic 
activity were blocked by LIMK inhibitor (Figs. 4 C and 5 A). 
The results from this study indicate that the latter two steps in-
volving invadopodia growth and maturation were sensitive to 
LIMK inhibition. Although the association of cortactin with co-
filin was reported to be sufficient to F-actin stabilization and   
invadopodia maturation (Oser et al., 2009), LIMK activity 
apparently also is required for adequate cofilin inactivation to 
complete maturation and formation of functional invadopodia.
The results from this study reveal that LIMK activity is 
crucial for the cellular processes that contribute to path genera-
tion, namely ECM degradation and force-mediated deformation 181 LIM kinases required for invasive path generation • Scott et al.
Figure 8.  Matrix contraction by cancer-associated fibroblasts requires LIMK activity. (A) Phosphorylation of myosin light chain on Ser19 (pS19-MLC) was 
significantly reduced by the ROCK inhibitor Y27632 but not by LIMKi (box equals upper and lower quartiles with line indicating median; whiskers are   
5 and 95% confidence intervals; n = 24–30). (B) Force-mediated remodeling by fibroblasts contracts matrix protein. Scoring the percentage of contraction 
area per well revealed significant inhibition of contraction by increasing LIMKi doses (average ± SEM, n = 3). (C) Cells transfected with LIMK1/2 siRNA 
relative to NT siRNA transfectants had reduced matrix contraction (average ± SEM, n = 3). (D) Knockdown of MT1-MMP reduced matrix contraction. 
(E) MT1-MMP knockdown did not affect MLC phosphorylation (box equals upper and lower quartiles with line indicating median; whiskers are 5 and 95% 
confidence intervals; n = 24–30 per treatment).JCB • VOLUME 191 • NUMBER 1 • 2010   182
would reduce the ability of tumor cells to move away from the 
primary tumor to the point where they would be able to intrava-
sate and enter the circulation. In a tumor such as prostate can-
cer, where the presence of a localized tumor may not be life 
threatening but mortality results from metastatic spread, the ef-
fect of LIMK inhibition on the levels of circulating tumor cells 
might be an intermediate endpoint in clinical trials to monitor 
disease status and progression that ultimately could be corre-
lated with survival to evaluate efficacy (Scher et al., 2009).
Materials and methods
Cell culture
MDA-MB-231 breast cancer cells were grown in DME with 10% fetal bo-
vine serum (FBS) and 2 mM l-glutamine plus 10 U/ml penicillin and 10 µg/ml 
streptomycin at 37°C in 5% CO2 in a humidified incubator. Cancer-associated 
fibroblasts were cultured in DME supplemented with 10% FBS, 1% ITS 
(insulin, transferrin, selenium), 2 mM l-glutamine, 10 U/ml penicillin, and 
10 µg/ml streptomycin. Organotypic skin model was performed as de-
scribed in Gaggioli et al. (2007), with the change that puromycin was 
used to kill cancer-associated fibroblasts rather than detergent extraction. 
Matrix contraction was quantified by scanning the plates and the diameter 
of the gel to well was measured using ImageJ software (http://rsbweb.nih 
.gov/ij). The extent of contraction was assessed by subtracting the gel area 
from the well area and percentage changes were calculated as described 
previously (Hooper et al., 2010).
of cancer” (Hanahan and Weinberg, 2000), then it would be pre-
dicted that the cofilin activity cycle should approach the most 
favorable operational state for increased invasive ability as cells 
progress from normal to cancerous, in which case tipping the 
levels of cofilin phosphorylation in either direction and restrict-
ing the ability of cofilin to dynamically cycle between active 
and inactivate states should decrease invasion. Consequently, 
robust LIMK inhibition should consistently decrease the inva-
siveness of highly metastatic cells by skewing the cofilin activ-
ity  cycle  away  from  optimal  by  driving  cofilin  toward  the 
dephosphorylated state and by limiting cycling. The results of 
this study indicate that the abilities of MDA-MB-231 breast 
cancer cells and CAFs to generate paths required for invasive-
ness were indeed inhibited by knockdown or pharmacological 
inhibition of LIMK.
In conclusion, we have shown that inhibition of LIMK ac-
tivity by siRNA-mediated knockdown or pharmacological inhi-
bition blocked the collective invasion of tumor cells by blocking 
activities required for path generation. A major challenge for 
the future will be to design clinical trials to test the effectiveness 
of anti-invasive therapeutic agents within a practical and cost-
effective time frame. One possibility is that LIMK inhibitors 
Figure 9.  Model of LIMK requirement in path-generating leading cells in collective invasion. (A) Leading cells degrade basement membrane (BM) and 
extracellular matrix (ECM) to generate a path of low mechanical resistance. Invadopodia undergo a growth and maturation process, developing at their 
site of birth. LIMK activity is required in the second step of invadopodia growth for stabilization of F-actin to allow for extension of the cytoskeleton. If the 
ability of the actin cytoskeleton to extend is impaired by LIMK inhibition, maturation cannot occur, which also impacts upon MMP delivery and results in 
reduced ECM proteolysis. (B) The path-generating activity may be provided by tumor or nontumor stromal cells. Following cells move through paths created 
by leading cells. LIMK activity allows for cytoskeletal structures required for ECM degradation and deformation to be formed. If LIMK activity is blocked in a 
cell subpopulation, either tumor or nontumor, they no longer have the ability to generate paths, but will follow paths generated by unaffected cells. Global 
LIMK inhibition blocks path generation leading to decreased invasion. By targeting the path-generating activity the contributions of tumor and nontumor 
stromal cells are inhibited.183 LIM kinases required for invasive path generation • Scott et al.
and the coated side placed on top of 100 µl of 0.5% gluteraldehyde (in 
PBS) for 10 min. The uncoated surfaces were then placed on 60 µl of 
488-nm fluorescent gelatin for 15 min. The coverslips were washed three 
times with PB and then with 5 mg/ml sodium borohydrate solution in PBS for 
3 min, and six further PBS washes before sterilizing the coverslips in 70% 
EtOH for 5 min. Finally, the EtOH was aspirated and the coverslips 
quenched in DMEM with 10% FBS for 1 h at 37°C. 3 × 10
4 cells were 
plated on fluorescent gelatin–coated coverslips in media containing 10 µM 
GM6001 MMP inhibitor and allowed to adhere at 37°C overnight. Cells 
were washed three times with PBS to remove the MMP inhibitor before the 
addition of complete media containing inhibitors as indicated. After 4 h, 
the coverslips were washed before 4% paraformaldehyde fixation and 
permeabilization with 0.1% Triton X-100 in PBS for 15 min. After blocking for 
30 min in 5% BSA, F-actin was stained with Texas red–conjugated phalloidin. 
Coverslips were mounted using ProLong Gold Antifade reagent and viewed 
on an upright fluorescent microscope.
Motility on cell-derived matrix
Sterilized coverslips were incubated with 0.2% gelatin for 1 h at 37°C, 
washed twice with PBS, then cross-linked with 1% glutaraldehyde for 30 min 
at room temperature. After two washes, cross-linker was quenched with 1 M 
glycine in PBS (pH 7) for 20 min at room temperature, washed twice with 
PBS, and then incubated with growth media for 30 min at 37°C before 
seeding with human dermal fibroblasts at 5 × 10
4 cells per well of a   
24-well plate. Cells were cultured at 37°C in 5% CO2 overnight before chang-
ing the media to complete media supplemented with 50 µg/ml ascorbic 
acid. The ascorbic acid media was changed every second day to increase 
collagen production and stabilize the matrix. Cells were removed with pre-
warmed extraction buffer (20 mM NH4OH and 0.5% Triton X-100 in PBS). 
Residual DNA was digested with 10 µg/ml DNase I in PBS containing cal-
cium and magnesium and incubated for 30 min at 37°C. Matrix-coated 
coverslips were washed twice then stored at 4°C in PBS containing penicil-
lin, streptomycin, and fungizone. Before use, coverslips were washed with 
PBS and incubated for 1 h at 37°C with DMEM. After cells were plated 
subconfluently, tissue culture dishes were transferred to a time-lapse micro-
scope with a 37°C, 5% CO2 incubation chamber for 1 h to allow cells to 
settle and for the plasticware to equilibrate. Images were taken using an 
inverted microscope system (Carl Zeiss, Inc.) with a 10x objective and 
bright-field channels at 15-min intervals over up to 24 h. Analysis of experi-
mental data was performed using ImageJ, or AndorIQ software.
Protein and mRNA preparation
RNA was isolated from MDA-MB-231 cells using the RNeasy kit according 
to the manufacturer’s instructions (QIAGEN). RNA was eluted with RNase-free 
water and stored at 220°C. Protein lysates were made and Western blotted 
as described previously (Coleman et al., 2001). In some instances Western 
blots were visualized with infrared fluorophore-conjugated secondary anti-
bodies and detected with an Odyssey system (LI-COR Biosciences).
cDNA synthesis and qPCR
RNA was reverse transcribed into cDNA with the Dynamo SYBR Green 2-step 
qRT-PCR kit according to the manufacturer’s instructions (Finnzymes). The qPCR 
reactions were performed as per the manufacturer’s instructions on a DNA 
Engine thermal cycler (Bio-Rad Laboratories) with a Chromo4 real-time PCR 
detector and Opticon Monitor 3 using the appropriate optimized protocol.
Antibodies
Antibodies were routinely used at 1:1,000 for Western blotting and 1:500 
for immunofluorescence. Antibodies used were: cofilin (Cell Signaling Tech-
nology); cofilin (Cytoskeleton, Inc.); LIMK1 (Cell Signaling Technology); 
LIMK2 (Santa Cruz Biotechnology, Inc.); -tubulin (Sigma-Aldrich); -tubulin 
(Sigma-Aldrich);  FLAG  (Sigma-Aldrich);  phospho-cofilin  (Cell  Signaling 
Technology);  MT1-MMP  (MMP14;  Neomarkers);  MMP9  (Neomarkers); 
cortactin (Millipore).
F-actin severing
G-actin was purified from rabbit muscle as described previously (Spudich 
and Watt, 1971) and maintained in G-buffer (2 mM Tris-Cl, pH 8.0, 0.2 mM 
ATP, 0.5 mM DTT, and 0.2 mM CaCl2). 1 mg/ml G-actin was labeled with 
5 mg/ml pyrene in dimethylformamide for 15 h and dialyzed in G-buffer. 
Actin polymerization was initiated by the addition of 50 mM KCl, 2 mM 
MgCl2, and 0.1 mM EGTA, and then ultracentrifuged to pellet the F-actin. 
The F-actin pellet resuspended in G-buffer and concentration determined. 
For the severing assay, G-actin (95% unlabeled, 5% pyrene labeled) was 
polymerized at 2.5 µM (G-actin final concentration) overnight. Labeled 
F-actin (50 µl at 2.5 µM) was added to a PTI glass cuvette (with or without 
siRNA transfection
All siRNA reagents were obtained from Thermo Fisher Scientific. Oligo-
fectamine was used for transfection of siRNA on subconfluent cells, accord-
ing to the manufacturer’s instructions. siRNA reference numbers and sense 
sequences are as follows: LIMK1-1, D-007730-01, GAACGCAGACCCUGA-
CUACUU; LIMK1-3, D-007730-03, UCAAGGAGGUGAAGGUCAUUU; 
LIMK2-6,  D-003311-06,  GAUCUGAACUCGCACAACUUU;  LIMK2-7,   
D-003311-07, UGACUGAGGUGAAAGUGAUUU.
Retrovirus production and transduction
Phoenix ecotropic packaging cells were transfected with pBABE puro GFP 
or RFP using Effectene (QIAGEN) according to the manufacturer’s instruc-
tions. 24 h later cells were washed twice and 1.5 ml of DMEM plus 10% FBS 
was added per well. Virus was collected after 48 h and centrifuged to re-
move any cells, and supernatant was stored at 280°C. Ecotropic receptor–
expressing MDA-MB-231 cells were infected with 1 ml of virus and 4 µl 
polybrene (4 mg/ml). The next day the media was replaced and cells were 
subsequently selected with puromycin. Uniform GFP or RFP expression was 
selected by flow cytometric sorting.
Recombinant protein preparation
Overnight cultures of pGEX-KG TAT-FLAG-COFILIN or pGEX-KG TAT-FLAG 
in BL21 (DE3) pLys
s were each diluted 1:10 and grown to OD600 0.6–1.0 
at 37°C before induction with 100 µM IPTG for 3 h at 37°C. Cells were 
pelleted, resuspended in 5 ml of PBS with 1x Complete protease inhibitor 
cocktail, and then disrupted by three 1-min rounds of sonication at 20% in-
tensity using a digital sonifier (model 250; Branson Ultrasonics). Debris 
was removed by centrifugation and clarified supernatants were incubated 
with  PBS-washed  glutathione–Sepharose  (GE)  bead  slurry  overnight  at 
4°C. Beads were washed with PBS and cofilin released from the GST moi-
ety by incubation with 100 units of bovine thrombin (Sigma-Aldrich) over-
night at 4°C. Alternatively, recombinant GST was eluted with 5 mM reduced 
glutathione overnight at 4°C. Supernatant was removed and incubated 
with 30 µl of washed p-aminobenzamidine beads (Sigma-Aldrich) for 1 h 
at room temperature to remove thrombin, before snap-freezing aliquots 
and storing at 280°C.
Cell migration assay
Cell migration assay was performed in Oris 96-well plates with rubber 
plugs in each well occluding a central portion. Once cells had settled, 
plugs were removed to create an identical central cell-free zone. After 24 h, 
cells were imaged on an upright tissue culture microscope using Qcapture-
Pro. To quantify the level of migration into the center of the well, cells were 
stained  Calcein  AM  and  scanned  with  a  plate  reader  (Safire2;  Tecan 
Group Ltd.).
Inverse invasion assay
Cell invasion assays were a modification of a method described previously 
(Hennigan et al., 1994). Complete matrigel was thawed on ice, diluted 
1:1 with PBS and then 100 µl of diluted matrigel pipetted into Transwell in-
serts in a 24-well tissue culture plate and left to incubate for 30 min at 
37°C to set. During this time, cell suspensions of 3 × 10
5 cells per ml from 
each condition were prepared in their normal growth medium. When the 
matrigel had set, the Transwell inserts were inverted and 100 µl of cell sus-
pension pipetted onto the filter. The Transwell inserts were then carefully 
covered with the base of the 24-well tissue culture plate, making contact 
with each cell suspension droplet, and the plate then incubated in the in-
verted state for 4 h to allow cell attachment. After this time, plates were 
turned right-side-up and each Transwell insert washed with 3 × 1 ml serum-
free DMEM and finally placed in a well containing any additional inhibi-
tors as indicated. DMEM plus 10% FBS was gently pipetted on top of the 
set matrigel/PBS mixture and incubated for 5 d at 37°C. Transwell inserts 
were placed in fresh 24-well dishes and 1 ml of 4 µM Calcein AM stain so-
lution pipetted on top. After 1 h of incubation at 37°C, cells were imaged 
by  confocal  microscopy  with  a  20x  objective  with  optical  Z-sections 
scanned at 15-µm intervals moving up from the underside of the filter into 
the matrigel. ImageJ software was used for quantification. Cells stably ex-
pressing RFP or GFP were paraformaldehyde fixed before imaging. Alter-
natively, propidium iodide (PI) was used to visualize nuclei after fixation 
with paraformaldehyde; F-actin staining was optionally stained with FITC-
conjugated phalloidin.
Gelatin degradation assay
Sterilized acid-washed 13-mm glass coverslips were placed on top of 100 µl 
of poly-l-lysine for 15 min at room temperature. Excess liquid was removed JCB • VOLUME 191 • NUMBER 1 • 2010   184
shows the colocalization of MMP9, cortactin, N-Wasp, and F-actin with inva-
dopodia. Fig. S5 shows MMP9 and MT1-MMP expression in SCC12 cells 
and CAFs. Video 1 shows rotating views of MDA-MB-231 invasion into 3D 
matrix. Stacks of confocal images were rendered into a rotating view of NT 
siRNA or LIMK1/2-transfected MDA-MB-231 cells using Volocity software. 
Strands of associated cells collectively invaded upward into matrix protein. 
Video 2 shows a time-lapse video of NT siRNA and LIMK1/2 siRNA trans-
fected MDA-MB-231 cell motility on fibroblast-derived matrix. Images were 
acquired at 10-min intervals for 16 h. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201002041/DC1.
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